PINZANI, MASSIMO
 Distribuzione geografica
Continente #
NA - Nord America 14.349
EU - Europa 8.933
AS - Asia 4.375
SA - Sud America 617
OC - Oceania 147
AF - Africa 108
Continente sconosciuto - Info sul continente non disponibili 4
Totale 28.533
Nazione #
US - Stati Uniti d'America 14.240
RU - Federazione Russa 3.141
PL - Polonia 1.764
SG - Singapore 1.340
HK - Hong Kong 1.015
SE - Svezia 885
CN - Cina 884
IE - Irlanda 800
UA - Ucraina 623
DE - Germania 520
BR - Brasile 519
IT - Italia 490
KR - Corea 472
FI - Finlandia 266
GB - Regno Unito 204
VN - Vietnam 178
IN - India 166
AU - Australia 139
FR - Francia 91
JO - Giordania 74
TR - Turchia 63
CA - Canada 56
AR - Argentina 43
JP - Giappone 39
CH - Svizzera 38
BE - Belgio 35
ID - Indonesia 31
MX - Messico 29
CI - Costa d'Avorio 27
NL - Olanda 27
ZA - Sudafrica 27
BD - Bangladesh 26
SC - Seychelles 23
ES - Italia 15
IQ - Iraq 15
UZ - Uzbekistan 14
EC - Ecuador 13
VE - Venezuela 12
CO - Colombia 10
PK - Pakistan 9
MA - Marocco 8
MY - Malesia 8
NZ - Nuova Zelanda 8
SA - Arabia Saudita 8
CL - Cile 6
KE - Kenya 5
LT - Lituania 5
NP - Nepal 5
PE - Perù 5
AZ - Azerbaigian 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
EE - Estonia 4
EG - Egitto 4
EU - Europa 4
HN - Honduras 4
JM - Giamaica 4
PT - Portogallo 4
PY - Paraguay 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AL - Albania 3
BY - Bielorussia 3
CZ - Repubblica Ceca 3
DZ - Algeria 3
OM - Oman 3
PA - Panama 3
PH - Filippine 3
TN - Tunisia 3
AT - Austria 2
BB - Barbados 2
BJ - Benin 2
CR - Costa Rica 2
GT - Guatemala 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LV - Lettonia 2
NG - Nigeria 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
BA - Bosnia-Erzegovina 1
BH - Bahrain 1
BO - Bolivia 1
CD - Congo 1
GR - Grecia 1
IL - Israele 1
IR - Iran 1
KH - Cambogia 1
KW - Kuwait 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
MG - Madagascar 1
NI - Nicaragua 1
PS - Palestinian Territory 1
RO - Romania 1
SD - Sudan 1
SN - Senegal 1
Totale 28.533
Città #
Santa Clara 2.695
Warsaw 1.758
Fairfield 1.486
Ashburn 1.050
Chandler 998
Jacksonville 980
Singapore 844
Hong Kong 826
Dublin 799
Woodbridge 662
Cambridge 597
Seattle 585
Houston 505
Wilmington 500
Seoul 470
Ann Arbor 328
Beijing 307
Princeton 216
Buffalo 199
Los Angeles 191
San Jose 189
Boardman 174
Boston 166
Hefei 163
Melbourne 137
The Dalles 125
Mumbai 116
Lawrence 113
Altamura 111
Dallas 110
Medford 100
Munich 98
Moscow 92
San Diego 69
Kent 62
Ho Chi Minh City 59
Florence 55
New York 49
Shanghai 47
Paris 46
São Paulo 46
Milan 43
Norwalk 43
Izmir 42
London 38
Turku 38
Bern 36
Brussels 35
Frankfurt Am Main 35
Tokyo 33
Auburn Hills 29
Hanoi 28
Abidjan 27
Andover 26
Hillsboro 24
Redondo Beach 24
West Jordan 22
Chicago 20
Jakarta 20
Dong Ket 18
Helsinki 18
Yubileyny 18
Frankfurt am Main 17
Montreal 17
Verona 17
Phoenix 16
Bremen 15
Toronto 15
Dearborn 14
Tianjin 14
San Francisco 13
Ottawa 12
Brooklyn 11
Curitiba 11
Johannesburg 11
Tashkent 11
Manchester 10
Rio de Janeiro 10
Stockholm 10
Falls Church 9
Guangzhou 9
Guarulhos 9
Hải Dương 9
Laurel 9
Miami 9
Rome 9
Brasília 8
Denver 8
Atlanta 7
Bagno a Ripoli 7
Belo Horizonte 7
Campinas 7
Chennai 7
Clifton 7
Council Bluffs 7
Da Nang 7
Dhaka 7
Fortaleza 7
Guayaquil 7
Poplar 7
Totale 19.127
Nome #
Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis 329
Antifibrogenic effects of canrenone, an antialdosteronic drug, on human hepatic stellate cells 323
Evaluation of intracellular signalling pathways in response to insulin-like growth factor I in apoptotic-resistant activated human hepatic stellate cells. 312
Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. 294
Differential expression of two isoforms of the chemokine receptor CXCR3 determines the ultimate effect of IP-10 on survival of human hepatic stellate cells (HSC) 292
Inhibition by pentoxifylline of extracellular signal-regulated kinase activation by platelet-derived growth factor in hepatic stellate cells 288
Intrabiliary metastasis from rectal cancer mimicking peripheral papillary-type cholangiocarcinoma. 280
Calcium-dependent activation of NF-kappa B by the adipokine resistin in hepatic stellate cells 272
Intermittent fever in a patient with apparent fatty liver 268
The mitogenic effect of platelet-derived growth factor in human hepatic stellate cells requires calcium influx 266
Fat-storing cells as liver-specific pericytes: spatial dynamic of agonist-stimulated intracellular calcium transients. 253
Welcome to Fibrogenesis & Tissue Repair 249
Mammalian target of rapamycin mediates the angiogenic effects of leptin in human hepatic stellate cells. 222
Hepatic wound repair. 216
Acute viral hepatitis increases liver stiffness values measured by transient elastography 209
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C 204
Reduced platelet thromboxane A2 production as a possible cause of defective platelet aggregation in cirrhosis. 203
4-Hydroxynonenal as a selective pro-fibrogenic stimulus for activated human hepatic stellate cells. 202
Activation of p38(MAPK) mediates the angiostatic effect of the chemokine receptor CXCR3-B. 196
The orphan nuclear receptor COUP-TFII coordinates hypoxia-independent proangiogenic responses in hepatic stellate cells 196
Liver stiffness correlates with methotrexate cumulative dose in patients with rheumatoid arthritis. 195
THE ACTIN CYTOSKELETON AS A NOVEL TARGET OF AMP-ACTIVATED PROTEIN KINASE (AMPK) IN HEPATIC STELLATE CELLS 194
Differential requirement of members of the MAPK family for CCL2 expression by hepatic stellate cells 191
MARCKS is a downstream effector in platelet-derived growth factor-induced cell motility in activated human hepatic stellate cells 189
Intracellular reactive oxygen species are required for directional migration of resident and bone marrow-derived hepatic pro-fibrogenic cells. 186
Upregulation of proinflammatory and proangiogenic cytokines by leptin in human hepatic stellate cells. 185
Mitotic Checkpoint CHK2 Upregulation is Linked to Chromosomal Instability in Human Hepatocellular Carcinoma 185
Prevention of severe toxic liver injury and oxidative stress in MCP-1-deficient mice 184
Adenosine monophosphate-activated protein kinase modulates the activated phenotype of hepatic stellate cells 182
NGF and Trk-A as a novel autocrine loop in the early stages of hepatic stellate cell (HSC) activation 181
Endothelin 1 is overexpressed in human cirrhotic liver and exerts multiple effects on activated hepatic stellate cells. 181
CXCR7 contributes to the aggressive phenotype of cholangiocarcinoma cells 181
ADMA correlates with portal pressure in patients with compensated cirrhosis. 180
Overexpression of Bcl-2 by activated human hepatic stellate cells: resistance to apoptosis as a mechanism of progressive hepatic fibrogenesis in humans. 178
Renal hemodynamic and natriuretic effects of human atrial natriuretic factor infusion in cirrhosis with ascites. 174
gp120 modulates the biology of human hepatic stellate cells: a link between HIV infection and liver fibrogenesis. 172
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial. 171
Neutrophil-derived superoxide anion induces lipid peroxidation and stimulates collagen synthesis in human hepatic stellate cells: role of nitric oxide. 171
Expression and function of integrin receptors for collagen and laminin in cultured human hepatic stellate cells. 168
Non-invasive assessment of liver fibrosis in patients with HBV-related chronic liver disease undergoing antiviral treatment: A preliminary study 168
Liver haploinsufficiency of RuvBL1 causes hepatic insulin resistance and enhances hepatocellular carcinoma progression 168
EFFECTS OF NITRIC OXIDE (NO)-DONORS ON ACTIVATED HUMAN HEPATIC STELLATE CELLS (HSC): CELLULAR BASIS FOR THE TREATMENT OF PORTAL HYPERTENSION. 167
Systemic hemodynamics and renal function in cirrhotic patients during plasma volume expansion. 166
MARCKS Actin Binding Capacity Mediates Actin Filament Assembly During Mitosis In Human Hepatic Stellate Cells. 166
Altered furosemide pharmacokinetics in chronic alcoholic liver disease with ascites contributes to diuretic resistance 166
Longitudinal assessment of liver stiffness in patients undergoing antiviral treatment for hepatitis C. 165
Expression of platelet-derived growth factor in newly formed cholangiocytes during experimental biliary fibrosis in rats. 164
Reliability of transient elastography for the diagnosis of advanced fibrosis in chronic hepatitis C 163
Expression of the thrombin receptor in human liver: up-regulation during acute and chronic injury. 163
Endothelin-1 inhibits secretin-stimulated ductal secretion by interacting with ETA receptors on large cholangiocytes. 162
Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis 160
Expression of platelet-derived growth factor in a model of acute liver injury. 158
Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma. 158
Agonist-specific regulation of monocyte chemoattractant protein-1 expression by cyclo-oxygenase metabolites in hepatic stellate cells 158
Biosynthesis of platelet-activating factor and its 1O-acyl analogue by liver fat-storing cells. 157
Fibrogenesi epatica: valutazione dell'espressione genica di citochine fibrogeniche e dei tipi più rappresentanti di collagene. 155
Nuclear localization of TRK-A in liver cells. 154
Acute effect of furosemide on renal kallikrein and prostaglandin systems in mild to moderate essential hypertension. 154
Albumin improves the response to diuretics in patients with cirrhosis and ascites: results of a randomized, controlled trial 154
Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis. 154
COMPARISON BETWEEN HEPATIC VENOUS PRESSURE GRADIENT (HVPG) AND LIVER STIFFNESS MEASUREMENT (LSM) IN PATIENTS WITH HCV-RELATED FIBROSIS/CIRRHOSIS 154
Binding of hepatitis C virus envelope protein E2 to CD81 induces the expression of MMP-2 (Gelatinase A) in human hepatic stellate cells. 152
Cross-talk between phosphatidylinositol 3-kinase (PI3-K) and the NA+/H+ exchanger in hepatic stellate cells (HSC): effect of canrenone. 152
Induction of procollagen type I gene expression and synthesis in human hepatic stellate cells by 4-hydroxy-2,3-nonenal and other 4-hydroxy-2,3-alkenals is related to their molecular structure. 151
Farnesoid X Receptor Critically Determines the Fibrotic Response in Mice but Is Expressed to a Low Extent in Human Hepatic Stellate Cells and Periductal Myofibroblasts. 151
Alcoholic and non-alcoholic fatty liver in adolescents: a worrisome convergence. 151
Thiazolidinedione treatment inhibits bile duct proliferation and fibrosis in a rat model of chronic cholestasis 150
Altered renal and platelet arachidonic acid metabolism in cirrhosis. 150
Liver stiffness is influenced by a standardized meal in patients with chronic hepatitis C virus at different stages of fibrotic evolution. 148
Performance of Doppler ultrasound in the prediction of severe portal hypertension in hepatitis C virus-related chronic liver disease 146
Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: The missing tool? 146
Albumin and stellate cell activation: wonders will never cease! 146
Actions of platelet-derived growth factor isoforms in mesangial cells. 145
Dose-dependent and divergent effects of superoxide anion on cell death, proliferation and migration of activated human hepatic stellate cells 143
Activation of focal adhesion kinase by PDGF is dependent on Ras in human hepatic stellate cells 143
Multiple biological effects of endothelin-1 in fat-storing cells isolated from human liver. 142
Defective Chromosome Segregation Causes DNA Damage and Chromosome Abnormalities In Human Hepatocellular Carcinoma 142
Thromboxane-receptor blockade increases water diuresis in cirrhotic patients with ascites. 141
Angiogenesis in liver disease. 141
Undulin RNA and protein expression in normal and fibrotic human liver. 141
Refining the Baveno VI elastography criteria for the definition of compensated advanced chronic liver disease 141
Progression of fibrosis in chronic liver diseases: time to tally the score. 140
Transient elastography (TE) is more effective for the identification of HCV patients with advanced (F3-F4) rather than significant (F2-F4) liver fibrosis 140
Effects of repeated atrial natriuretic peptide bolus injections in cirrhotic patients with refractory ascites. 140
Transient elastography (TE) is more effective for the identification of HCV patients with severe (> F3) rather than significant (> F2) liver fibrosis 140
Stellate Cells 139
Monocyte chemotactic protein-1 as a chemoattractant for human hepatic stellate cells. 137
Integrin-mediated stimulation of monocyte chemotactic protein-1 expression. 136
Signal transduction by the chemokine receptor CXCR3 - Activation of Ras/ERK, Src, and phosphatidylinositol 3-kinase/Akt controls cell migration and proliferation in human vascular pericytes 136
Serum markers detect the presence of liver fibrosis: a cohort study. 135
The cellular and molecular basis of liver fibrogenesis. 134
Regulation of platelet-derived growth factor secretion and gene expression in human liver fat-storing cells. 134
Up-regulated expression of fractalkine and its receptor CX3CR1 during liver injury in humans 134
The chemokine CCL21 modulates lymphocyte recruitment and fibrosis in chronic hepatitis C. 133
Fibrosis in chronic liver diseases: diagnosis and management 133
Purification of PGE2 in the urine of cirrhotic patients: comparison of three chromatographic techniques. 132
Endothelin-1 is overexpressed in cirrhotic liver and exerts multiple effects on activated human hepatic stellate cells. 132
Immediate effects of furosemide on renal hemodynamics in chronic liver disease with ascites. 131
Elastography for the non-invasive assessment of liver disease: limitations and future developments 130
A Secreted Form of ADAM9 by Hepatic Stellate Cells Induces Tumor Invasion Through Stromal-tumor Interactions 129
Totale 17.543
Categoria #
all - tutte 73.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.296


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.184 0 0 0 0 0 0 61 256 168 330 128 241
2021/20221.356 62 134 52 60 58 64 51 75 86 51 304 359
2022/20233.661 375 460 153 346 351 687 453 232 441 21 84 58
2023/20241.048 63 151 229 58 46 111 25 249 7 33 51 25
2024/20258.201 235 929 579 1.315 2.462 881 116 465 472 221 270 256
2025/20264.646 1.025 1.179 566 448 893 262 273 0 0 0 0 0
Totale 28.602